Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA ...

ACC/AHA guidelines updated for dyslipidemia management

In a clinical practice guideline issued by the American College of Cardiology, the American Heart Association, and nine other leading medical associations, updated recommendations are presented for managing dyslipidemia. The clinical practice guideline was published online March 13 in the Journal of the American College of Cardiology and in Circulation.

Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA ...

– Bempedoic Acid Receives Strongest Endorsement from AHA/ACC Multisociety Guideline for Patients with Statin Intolerance and in Primary and Secondary Prevention Patients with Severe Hypercholesterolemia –

ACC/AHA Release 2026 Guideline on Dyslipidemia Management: Earlier Treatment, New Risk Tools, and Lower LDL Targets Recommended

The American College of Cardiology (ACC) and the American Heart Association (AHA) have released the 2026 ACC/AHA Guideline on the Management of Dyslipidemia, introducing several important updates in...